The Impact of Punica granatum Linn and Its Derivatives on Oxidative Stress, Inflammation, and Endothelial Function in Diabetes Mellitus: Evidence from Preclinical and Clinical Studies

Diabetes mellitus is recognized as the leading contributor to cardiovascular disease and associated mortality rates worldwide. Despite the use of pharmaceutical drugs to treat diabetes, its prevalence continues to rise alarmingly. Therefore, exploring remedies with a lower toxicity profile is crucial while remaining safe and effective in addressing this global public health crisis. Punica granatum Linn (pomegranate), known for its properties and safety profile, has been investigated in applied research and preclinical and clinical trials. However, conflicting reports still exist regarding its effects in diabetes. According to our knowledge, no systematic review has been conducted to critically analyze evidence from preclinical and clinical trials simultaneously, explicitly focusing on oxidative stress, inflammation, and endothelial function in diabetes. Therefore, in this systematic review, we searched for evidence on the impact of pomegranate in diabetes using databases such as PubMed, Scopus, and Google Scholar. Our inclusion criteria were limited to studies published in English. Of the 170 retrieved studies, 46 were deemed relevant and underwent critical analysis. The analyzed evidence suggests that pomegranate has the potential to alleviate oxidative stress, inflammation, and endothelial dysfunction in diabetes. Although a beneficial impact was noted in these markers, the endothelial function evidence still requires validation through further clinical trials with a powered sample size.

Automated summary

Diabetes mellitus is a major contributor to cardiovascular disease and mortality rates worldwide. Despite the use of pharmaceutical drugs, diabetes prevalence is alarmingly rising, necessitating the search for remedies with lower toxicity. Pomegranate, known for its properties and safety, has been investigated in research and trials. However, conflicting reports exist on its effects in diabetes. Therefore, this systematic review analyzed evidence from preclinical and clinical trials, focusing on oxidative stress, inflammation, and endothelial function in diabetes. The analyzed evidence suggests that pomegranate has the potential to alleviate these markers, but further clinical trials are needed for validation.